C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload SD Whatley, S Ducamp, L Gouya, B Grandchamp, C Beaumont, ... The American Journal of Human Genetics 83 (3), 408-414, 2008 | 321 | 2008 |
A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria PN Meissner, TA Dailey, RJ Hift, M Ziman, AV Corrigall, AG Roberts, ... Nature genetics 13 (1), 95-97, 1996 | 247 | 1996 |
The acute porphyrias GH Elder, RJ Hift, PN Meissner The Lancet 349 (9065), 1613-1617, 1997 | 225 | 1997 |
An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity RJ Hift, PN Meissner Medicine 84 (1), 48-60, 2005 | 191 | 2005 |
Liver disease in erythropoietic protoporphyria: insights and implications for management AV Anstey, RJ Hift Postgraduate medical journal 83 (986), 739-748, 2007 | 172 | 2007 |
Porphyrias MFM James, RJ Hift British Journal of Anaesthesia 85 (1), 143-153, 2000 | 164 | 2000 |
Should essays and other “open-ended”-type questions retain a place in written summative assessment in clinical medicine? RJ Hift BMC Medical Education 14, 1-18, 2014 | 140 | 2014 |
Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non‐melanoma skin cancer in an at‐risk population: a cohort study M Setshedi, D Epstein, TA Winter, L Myer, G Watermeyer, R Hift Journal of gastroenterology and hepatology 27 (2), 385-389, 2012 | 121 | 2012 |
Variegate porphyria RE Kirsch, PN Meissner, RJ Hift Seminars in liver disease 18 (01), 33-41, 1998 | 101 | 1998 |
A structured assessment of newly qualified medical graduates VC Burch, RC Nash, T Zabow, T Gibbs, L Aubin, B Jacobs, RJ Hift Medical education 39 (7), 723-731, 2005 | 94 | 2005 |
Women's perceptions of the benefits and risks of skin‐lightening creams in two South African communities N Dlova, SH Hamed, J Tsoka‐Gwegweni, A Grobler, R Hift Journal of cosmetic dermatology 13 (3), 236-241, 2014 | 86 | 2014 |
Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of … RJ Hift, BP Davidson, C van der Hooft, DM MEIssNER, PN Meissner Clinical chemistry 50 (5), 915-923, 2004 | 84 | 2004 |
Homozygous variegate porphyria: an evolving clinical syndrome RJ Hift, PN Meissner, G Todd, P Kirby, D Bilsland, P Collins, J Ferguson, ... Postgraduate medical journal 69 (816), 781-786, 1993 | 73 | 1993 |
Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity RJ Hift, S Thunell, A Brun Pharmacology & therapeutics 132 (2), 158-169, 2011 | 72 | 2011 |
South African medical schools: current state of selection criteria and medical students’ demographic profile LJ Van der Merwe, GJ Van Zyl, ASC Gibson, A Viljoen, JE Iputo, ... South African Medical Journal 106 (1), 76-81, 2016 | 71 | 2016 |
The spectrum of skin diseases in a black population in D urban, K waZulu‐Natal, S outh Africa NC Dlova, A Mankahla, N Madala, A Grobler, J Tsoka‐Gwegweni, RJ Hift International journal of dermatology 54 (3), 279-285, 2015 | 69 | 2015 |
Anaesthesia for the porphyric patient GG Harrison, PN Meissner, RJ Hift Anaesthesia 48 (5), 417-421, 1993 | 69 | 1993 |
Drugs in the acute porphyrias--toxicogenetic diseases. MR Moore, RJ Hift Cellular and Molecular Biology (Noisy-le-Grand, France) 43 (1), 89-94, 1997 | 60 | 1997 |
Treatment of acute porphyria GH Elder, RJ Hift Hospital Medicine 62 (7), 422-425, 2001 | 59 | 2001 |
A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the ‘Royal Malady’ RJ Hift, TJ Peters, PN Meissner Journal of clinical pathology 65 (3), 200-205, 2012 | 53 | 2012 |